Workflow
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
GlobeNewswire· 2025-05-19 13:00
HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced the appointment of Michael Tung, M.D., MBA as Executive Vice President and Chief Financial Officer, effective immediately. Dr. Tung joins the Company with 20 years of diversified finance, corporate strategy, investor relations, and business development experience in the biopharmaceutical industry. This executive appointment comes at an important time for the Compan ...
Tejon Ranch Announces Final Voting Results of 2025 Annual Meeting of Shareholders
GlobeNewswire· 2025-05-19 13:00
TEJON RANCH, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today announced that, based on the final vote count certified by the independent election inspector following the Company’s 2025 Annual Meeting of Shareholders, Tejon shareholders have voted to re-elect Steven Betts, Gregory Bielli, Denise Gammon, Anthony Leggio, Jeffrey McCall, Norman Metcalfe, Eric Speron, Daniel Tisch and Kenneth Yee ...
Varonis Becomes the First Data Security Platform to Achieve FedRAMP Authorization
GlobeNewswire· 2025-05-19 13:00
Federal certification affirms that Varonis’ unified platform meets rigorous cloud security requirements mandated by U.S. federal agenciesMIAMI, May 19, 2025 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS), the leader in data security, proudly announces that its cloud-native Data Security Platform is the first in its category to achieve Federal Risk and Authorization Management Program (FedRAMP®) Authorization. The industry milestone confirms that Varonis’ AI-driven platform aligns with rigorous sta ...
Viomi Unveils Next-Generation Mineral Water Purifiers, Leading Household Drinking Water into the Era of Pure Mineral Water
GlobeNewswire· 2025-05-19 12:45
GUANGZHOU, China, May 19, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced the official launch of its groundbreaking Kunlun 4 Pro Alkaline Mineral Water Purifier. Unveiled at a special product event held on May 16th, this next-generation water purifier harnesses AI technology to replicate the natural mineral water formation process, aiming to elevate household drinking water from the ...
MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results
GlobeNewswire· 2025-05-19 12:44
TOKYO, May 19, 2025 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic healthcare company based in Japan (the “Company” or “MEDIROM”) today announced that it will host a webcast to review the Company’s financial results for the fiscal year ended December 31, 2024, on Wednesday, May 21, 2025 at 8:30 am Eastern Time. The Company will issue a press release discussing those results after the market close on Tuesday, May 20th, 2025. In addition, on April 29, 2025, the Company f ...
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
GlobeNewswire· 2025-05-19 12:31
-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology -- -- On-track to file IND and/or CTA for Wilson’s Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 -- -- Allan Reine, M.D., CFO, to succeed Keith Gottesdiener, M.D., as CEO; Jeff Marrazzo, member of the Board of Directors, named Executive Chair -- -- Implementing cost cutting mea ...
Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
GlobeNewswire· 2025-05-19 12:30
-- First ever clinical data supporting safety and efficacy of Prime Editing in humans -- -- Initial data from first patient dosed in Phase 1/2 trial finds single dose of PM359 led to 58% DHR positivity by Day 15 and 66% by Day 30, well above levels believed to be potentially curative -- -- Rapid engraftment observed in both neutrophils and platelets -- -- Encouraging safety profile; no serious adverse events related to PM359 -- -- Initiating efforts to explore continued clinical development opportunities fo ...
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
GlobeNewswire· 2025-05-19 12:30
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approachesNEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, (the “ ...
Lifeward Names Mark Grant as New CEO
GlobeNewswire· 2025-05-19 12:30
Industry veteran brings 30 years of commercial leadership experienceMARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Mark Grant has been appointed as the Company’s new President and Chief Executive Officer, effective June 2, 2025. Larry Jasinski, Lifeward’s outgoing CEO, will ...
REalloys Inc., Signs Joint MOU with Saskatchewan Research Council Enabling Processing of Rare Earth Materials for High Performance Magnet Production in Q2 2025
GlobeNewswire· 2025-05-19 12:30
DALLAS, May 19, 2025 (GLOBE NEWSWIRE) -- Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), announces that its merger target REalloys Inc. (“REA” or “REalloys”), has signed a joint Memorandum of Understanding (“MOU”) with the Saskatchewan Research Council (“SRC”) to begin working together to advance REA’s initiative of commercial production of high-performance rare earth magnet materials. REA’s planned production starts in Q2, with targeted expansion to 500 metric tonnes (“mt”) per year of m ...